Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders.
Yi S, Li Z, Zou D, Xiong W, Li H, Cui R, Li C, Yan Y, Liu W, Lv R, Yu Z, Chen W, Xu Y, An G, Wang H, Ru K, Cheng T, Wang J, Qiu L.
Yi S, et al. Among authors: xu y.
Oncotarget. 2017 Dec 15;9(3):3353-3364. doi: 10.18632/oncotarget.23261. eCollection 2018 Jan 9.
Oncotarget. 2017.
PMID: 29423051
Free PMC article.